Detalhe da pesquisa
1.
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma.
N Engl J Med
; 390(15): 1359-1371, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38631003
2.
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma.
N Engl J Med
; 384(14): 1289-1300, 2021 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33616314
3.
Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database.
Br J Cancer
; 129(11): 1759-1765, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37777577
4.
Metabolomic identification of predictive and early biomarkers of cisplatin-induced acute kidney injury in adult head and neck cancer patients.
Br J Clin Pharmacol
; 2023 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36657745
5.
Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer: Treatment Optimization for Maximum Clinical Benefit.
Oncologist
; 27(7): 565-572, 2022 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35482606
6.
Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial.
BMC Cancer
; 20(1): 125, 2020 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32059705
7.
Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial.
Lancet Oncol
; 20(10): 1349-1359, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31416685
8.
Emerging cell cycle inhibitors for treating metastatic castration-resistant prostate cancer.
Expert Opin Emerg Drugs
; 23(4): 271-282, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30422005
9.
Late Relapse of Ovarian Germ Cell Tumour.
J Obstet Gynaecol Can
; 40(10): 1329-1332, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30390946
10.
Bone Health and Bone-Targeted Therapies for Nonmetastatic Prostate Cancer: A Systematic Review and Meta-analysis.
Ann Intern Med
; 167(5): 341-350, 2017 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28785760
11.
Dose dense MVAC prior to radical cystectomy: a real-world experience.
World J Urol
; 35(11): 1729-1736, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28625005
12.
Abiraterone in metastatic prostate cancer without previous chemotherapy.
N Engl J Med
; 368(2): 138-48, 2013 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23228172
13.
Sunitinib maintenance therapy after response to docetaxel in metastatic castration resistant prostate cancer (mCRPC).
Invest New Drugs
; 34(6): 771-776, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27565809
14.
Safety of enzalutamide in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: expanded access in North America.
Prostate
; 75(8): 836-44, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25683285
15.
Temsirolimus Maintenance Therapy After Docetaxel Induction in Castration-Resistant Prostate Cancer.
Oncologist
; 20(12): 1351-2, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26542984
16.
Identification and survival outcomes of a cohort of patients with cancer of unknown primary in Ontario, Canada.
Acta Oncol
; 54(10): 1781-7, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25825957
17.
Exemestane for breast-cancer prevention in postmenopausal women.
N Engl J Med
; 364(25): 2381-91, 2011 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-21639806
18.
Tamoxifen-associated hot flash severity is inversely correlated with endoxifen concentration and CYP3A4*22.
Breast Cancer Res Treat
; 145(2): 419-28, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24744093
19.
Application of a policy framework for the public funding of drugs for rare diseases.
J Gen Intern Med
; 29 Suppl 3: S774-9, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25029973
20.
Toward a functional definition of a "rare disease" for regulatory authorities and funding agencies.
Value Health
; 17(8): 757-61, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25498770